21 Drug Makers Expect 1.6% Increase in Sales but Decline in Profits in FY2017

By Reiji Anasako Twenty-one Japanese drug makers are likely to report an overall 1.6% increase in sales and 1.2% decline in operating profit for the fiscal year ending March 2018. Though global products have been doing well, the domestic market...read more